The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy

被引:15
作者
Coughlan, Monica [1 ,2 ]
Elstrom, Rebecca [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Stanford Univ, Sch Med, Palo Alto, CA 94305 USA
关键词
Lymphoma; Surrogate endpoint; Positron emission tomography; POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; BONE-MARROW INVOLVEMENT; INTERNATIONAL WORKSHOP; F-18-FDG PET; RESPONSE ASSESSMENT; PROGNOSTIC VALUE; ELDERLY-PATIENTS; INTERIM; CRITERIA;
D O I
10.1186/s40644-014-0034-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Positron emission tomography (PET) using (18)fluoro-2-deoxyglucose (FDG) has become a standard clinical tool for staging and response assessment in aggressive lymphomas. The use of PET scans in clinical trials is still under exploration, however. In this review, we examine current data regarding PET in DLBCL, and its potential applicability to development of a surrogate endpoint to expedite clinical trial conduct. Interim PET scanning in DLBCL shows mixed results, with qualitative assessment variably associated with outcome. Addition of quantitative assessment might improve predictive power of interim scans. Data from multiple retrospective studies support that PET-defined response at end of treatment correlates with outcome in DLBCL. Optimal technical criteria for standardization of acquisition and criteria for interpretation of scans require further study. Prospective studies to define the correlation of PET-defined response and time-dependent outcomes such as progression free survival (PFS) and overall survival (OS), critical for development of PET as a surrogate endpoint for clinical trials, are ongoing. In conclusion, evolving data regarding utility of PET in predictcing outcome of patients with DLBCL show promise to support the use of PET as a surrogate endpoint in clinical trials of DLBCL in the future.
引用
收藏
页数:9
相关论文
共 57 条
[1]
Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. ;
Fijnheer, Rob ;
Dubois, Stefan V. ;
Nievelstein, Rutger A. J. ;
de Klerk, John M. H. .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (07) :726-731
[2]
FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. ;
de Keizer, Bart ;
Fijnheer, Rob ;
de Klerk, John M. H. ;
Nievelstein, Rutger A. J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (03) :565-574
[3]
A unifying approach for surrogate marker validation based on Prentice's criteria [J].
Alonso, A ;
Molenberghs, G ;
Geys, H ;
Buyse, M ;
Vangeneugden, T .
STATISTICS IN MEDICINE, 2006, 25 (02) :205-221
[4]
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma [J].
Barrington, Sally F. ;
Qian, Wendi ;
Somer, Edward J. ;
Franceschetto, Antonella ;
Bagni, Bruno ;
Brun, Eva ;
Almquist, Helen ;
Loft, Annika ;
Hojgaard, Liselotte ;
Federico, Massimo ;
Gallamini, Andrea ;
Smith, Paul ;
Johnson, Peter ;
Radford, John ;
O'Doherty, Michael J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (10) :1824-1833
[5]
Fundamentals of PET and PET/CT imaging [J].
Basu, Sandip ;
Kwee, Thomas C. ;
Surti, Suleman ;
Akin, Esma A. ;
Yoo, Don ;
Alavi, Abass .
PET/CT APPLICATIONS IN NON-NEOPLASTIC CONDITIONS, 2011, 1228 :1-18
[6]
FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases [J].
Beat, KP ;
Yeung, HW ;
Yahalom, J .
ANNALS OF ONCOLOGY, 2005, 16 (03) :473-480
[7]
In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy [J].
Berthet, Louis ;
Cochet, Alexandre ;
Kanoun, Salim ;
Berriolo-Riedinger, Alina ;
Humbert, Olivier ;
Toubeau, Michel ;
Dygai-Cochet, Inna ;
Legouge, Caroline ;
Casasnovas, Olivier ;
Brunotte, Francois .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (08) :1244-1250
[8]
PET/CT: Form and function [J].
Blodgett, Todd M. ;
Meltzer, Carolyn C. ;
Townsend, David W. .
RADIOLOGY, 2007, 242 (02) :360-385
[9]
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials [J].
Boellaard, Ronald ;
Oyen, Wim J. G. ;
Hoekstra, Corneline J. ;
Hoekstra, Otto S. ;
Visser, Eric P. ;
Willemsen, Antoon T. ;
Arends, Bertjan ;
Verzijlbergen, Fred J. ;
Zijlstra, Josee ;
Paans, Anne M. ;
Comans, Emile F. I. ;
Pruim, Jan .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (12) :2320-2333
[10]
PET and PET/CT imaging: What clinicians need to know [J].
Bybel, Bohdan ;
Wu, Guiyun ;
Brunken, Richard C. ;
Turbiner, Elliott ;
Shah, Shetal N. ;
Neumann, Donald R. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (12) :1075-1087